Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view
Titel:
Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view
Auteur:
NEVEN, P. PARIDAENS, R. AMANT, F. WILDIERS, H. BERTELOOT, P. LEUNEN, K. SMEETS, A. WELTENS, C. van den BOGAERT , W. van LIMBERGEN , E. CHRISTIAENS, M.R. VERGOTE, I.